Furthermore, it has been demonstrated that nuclear MAGEA4 expression in the absence of nuclear TP53 expression results in poorer survival of NSCLC patients compared with cytoplasmic MAGEA4 [45]. The gene discussed is MAGEA4; the disease is non-small cell lung carcinoma.